Centene Corp Liquidation Value

CNC Insurance
Note: Insurance companies may use non-standard XBRL balance sheet reporting. Standard liquidation metrics may not be available for all periods. Data shown reflects what was reported in SEC EDGAR filings.

Cash & Equivalents

$21.26B
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $21.26B
Total Obligations: -$56.35B
$-35.09B
Per share: $-71.06
Period: 2026-03-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Finance Lease Liability: not reported in this period (annual-only)
  • Operating Lease Liability: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $21.26B
AR: N/A
Total Obligations: -$56.35B
$-35.09B
Per share: $-71.06
Period: 2026-03-31
incomplete 3 components missing — treated as $0 in formula. Why?
  • Finance Lease Liability: not reported in this period (annual-only)
  • Operating Lease Liability: not reported in this period (annual-only)
  • Accounts Receivable: not reported

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $21.26B
AR: N/A
Inventory: N/A
Total Obligations: -$56.35B
$-35.09B
Per share: $-71.06
Period: 2026-03-31
incomplete 4 components missing — treated as $0 in formula. Why?
  • Finance Lease Liability: not reported in this period (annual-only)
  • Operating Lease Liability: not reported in this period (annual-only)
  • Accounts Receivable: not reported
  • Inventory: not reported

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-35.09B$-71.06
Liquid Liquidation Value$-35.09B$-71.06
Operating Liquidation Value$-35.09B$-71.06

Key Components (as of 2026-03-31)

Note: Financial institutions (banks, REITs, insurance companies) use specialized accounting standards that differ from standard GAAP balance sheet presentation. Liquidation metrics may not apply and are shown as N/A where data is unavailable. See our methodology page for details.

Data as of 2026-03-31 from 10-Q filed 2026-04-28. View on SEC EDGAR →

Cash & Equivalents$21.26B
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$40.05B
Long-term Debt$16.31B
Op. Lease LiabilityN/A
Finance LeaseN/A
Shares Outstanding493.8M

Explore all 137 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$21.26BN/AN/AN/A$40.05B$16.31BN/AN/A
2025-12-31$17.89BN/AN/AN/A$36.70B$17.35B$615.00MN/A
2025-09-30$17.06BN/AN/AN/A$40.63B$17.55BN/AN/A
2025-06-30$14.51BN/AN/AN/A$36.79B$17.55BN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-04-28 View
2025-12-31 10-K 2026-02-17 View
2025-09-30 10-Q 2025-10-29 View
2025-06-30 10-Q 2025-07-25 View
2025-03-31 10-Q 2025-04-25 View
2024-12-31 10-K 2025-02-18 View
2024-09-30 10-Q 2024-10-25 View
2024-06-30 10-Q 2024-07-26 View

AI Insights

AI Insight·Generated 2026-05-04

Centene Corp (CNC) presents a deeply negative liquidation posture consistent with a managed care organization built on acquisition-driven intangible asset accumulation layered over a structurally levered balance sheet. As of March 31, 2026, reported total assets of $81.2B face severe haircuts under a liquidation lens: cash and cash equivalents of $21.3B recover at par; short-term investments of $2.5B and long-term investments of $16.6B (predominantly fixed-income) recover near par with modest duration/liquidity discount; net PP&E of $2.1B recovers at 50-70%, yielding roughly $1.1-1.5B; and the intangible asset stack — goodwill of $10.8B plus other intangibles of $4.4B totaling $15.2B — receives a 0% recovery, representing the single largest destruction of stated asset value in a wind-up scenario. Premiums receivable of $19.4B are largely government obligors (Medicaid/Medicare) and recover at 90-95% under normal collection assumptions, though government contract receivables in runoff carry execution risk. On the liability side, total debt of $16.4B (face value, net of issuance costs) stands at face, medical claims liabilities of $20.6B stand at face, and current liabilities of $40.0B including AP/accruals of $16.8B settle at book. The MFFAIS-reported liquidation value of negative $35.1B reflects this asymmetry. The debt stack improved modestly quarter-over-quarter: total senior notes declined from $15.5B to $14.5B following $1.0B in open-market repurchases of the 2027 maturity during Q1 2026, and the Term Loan declined from $2.0B to $2.0B (negligible amortization). Debt-to-capital fell from 46.5% to 43.2%. No new debt issuance was recorded. The goodwill balance at $10.8B is unchanged quarter-over-quarter, indicating no impairment test triggers. The $3.0B Part D CMS risk-sharing receivable retained on balance sheet (net of $1.0B sold under a receivable purchase facility) introduces contingent recovery risk if CMS payment timing is delayed. A pending federal securities class action (filed July 2025) and five related derivative actions present unquantified contingent liability exposure not currently reserved.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...